Infectious Disease

Study hopes to overcome significant challenges in producing an HIV vaccine.

Denmark is close to eradicating HIV through a prevention approach.

Association found between persistent immune activation, arterial inflammation, and plaque development in HIV

The critical beginning stages of HIV have been found to be less symptomatic than previously thought.

Neutron crystallography improves insight about the enzyme HIV-1 protease.

Patients receiving same-day treatment for HIV were more likely to start antiretroviral therapy and had better viral suppression.

Potent broadly neutralizing antibody binds to HIV and causes a strong immune response.

Adherence to antiretroviral treatment negatively affected among patients with HIV who use drugs.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

Current HIV criminalization laws may be unfairly biased due to assumptions about intent to transmit the virus in sexual activity.

Top news of the day from across the health care landscape.

Research may lead to new drugs that boost the immune response to HIV.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Engineered immunogens incite the immune system to produce antibodies that show promise for an HIV vaccine.

The CDC recently confirmed man-to-man sexual transmission of the Zika virus.

Injections of new formulation of raltegravir may only be needed every month.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

Tuberculosis is difficult to detect in patients with HIV.

Risk of cardiovascular events increases in HIV patients who defer or interrupt treatment.

DNA screening technology up to 10,000 times more sensitive than current tests for cancer and HIV.

Pharmacists can reduce inappropriate PPI use and help patients discontinue unnecessary PPIs through these interventions.

When historical data dominates, controversy is sure to exist. Such is the case for the use of antibiotics in patients with group A streptococcal pharyngitis.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.

Carbapenems are often considered to have the broadest spectrum of activity among all antibiotic classes.

Solithromycin, the first drug in the fluoroketolide class of macrolide antibiotics, recently demonstrated noninferiority to moxifloxacin in the treatment of community-acquired bacterial pneumonia.